Henry Schein (HSIC) Inc continues to generate interest as companies like Envestnet Portfolio Solutions and Nordea Investment Management increase their holdings in HSIC. In the face of HSIC's underperformance in the market and contrasting fluctuations in stock value, firms like Mirae Asset Global Investments Co. Ltd. and Daiwa Securities Group Inc. maintain significant investments. Despite macroeconomic challenges, HSIC is actively engaged in strategic purchases. Various financial predictions highlight impressive gains for HSIC come Q2 2024. Leerink Partners has adjusted their earnings forecast for Q3 2024 indicating a dynamic profit landscape. Presented with a new $72.00 price target from Evercore ISI, HSIC may see a better financial frame. Recently, the company has faced a setback due to a cyberattack. Its cyber security incident affecting Q4 performance is a temporary hiccup, with experts expressing optimism about the dental sector. HSIC's venture into the orthopedic market via a new acquisition, entry in the extremities sections, and partnership with Viome for oral health solutions show continued expansion. Despite a fall after Q1 outcomes, indicators suggest HSIC to be a firm player in the long run.
Henry Schein HSIC News Analytics from Mon, 31 Jul 2023 07:00:00 GMT to Sun, 14 Jul 2024 14:44:40 GMT -
Rating 5
- Innovation 3
- Information 7
- Rumor -2
